News

1 to 9 of 95854 results

EXPERT VIEW: Pfizer and AstraZeneca, a marriage not to be – yet?

EXPERT VIEW: Pfizer and AstraZeneca, a marriage not to be – yet?

19-08-2014

Mergers and acquisitions may excite the markets and shareholders on both sides but their record of success…

GlobalInterviewsMergers & AcquisitionsPharmaceutical

Pfizer files palbociclib NDA with FDA for breast cancer

Pfizer files palbociclib NDA with FDA for breast cancer

19-08-2014

US pharma giant Pfizer says it has completed the submission of a New Drug Application to the US Food…

OncologypalbociclibPfizerPharmaceuticalRegulationUSA

Provectus opens negotiations on licensing PV-10 in China

Provectus opens negotiations on licensing PV-10 in China

19-08-2014

US developmental stage company Provectus Biopharmaceuticals has entered into a memorandum of understanding…

Breast cancerChinaLicensingMemorandum of understandingOncologyPharmaceuticalProvectus BiopharmaceuticalsPV-10Sinopharm

AstraZeneca reports positive results from Phase III antibiotic study

AstraZeneca reports positive results from Phase III antibiotic study

19-08-2014

Anglo-Swedish drug major AstraZeneca has achieved positive results from the pivotal Phase III studies…

ActavisAntibiotics and Infectious diseasesAstraZenecaavibactamCeftazidimeComplicated intra-abdominal infectionsForest LaboratoriesMedicinePharmaceuticalResearchSerious bacterial infectionsUK

Novartis makes investment in stem cell company Gamida Cell with option agreement

Novartis makes investment in stem cell company Gamida Cell with option agreement

19-08-2014

Swiss drug major Novartis has signed an investment and option agreement with Israeli stem cell specialist…

BiotechnologyFinancialGamida CellHematologyIsraelNovartisStem cell specialistSwitzerland

1 to 9 of 95854 results

Back to top